
Dr David Lloyd
Managing Director

Managing Director

Business Development
Discover new opportunities and partnerships at BIO Korea 2025, an event uniting the APAC biotechnology and pharmaceutical community.
As a full-service contract research organization, Southern Star Research specializes in accelerating your journey from concept to commercialization. With our experienced team, bespoke solutions and transparent approach, we’re proud to be the Asia-Pacific’s most trusted CRO.
Connect with us at BIO Korea 2025 to learn how we can guide you and your product through the complexities of running a clinical trial.
"*" indicates required fields
Cost
Speed
Quality
L1, 1 Merriwa Street,
Gordon, NSW, 2072 Australia
Connect with us
Keep up to date with the latest news, updates and promotions
"*" indicates required fields
Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.
By clicking 'SUBSCRIBE NOW', you agree that Southern Star Research may collect and use your personal data for these marketing and communication purposes.
Each member of our Leadership Team boasts an average of 30 years experience. Our clients have access to an extraordinary group of Clinical Research professionals, whose experience covers Multinational Pharmaceutical companies, Biotechnology, Medical Device, CRO’s, research institutes, Universities, Industry Associations & Government Bodies. Together, we ensure that every aspect of your unique and novel drug study clinical trial is handled with scientific precision, care, and foresight.
Our team has all of the tools, knowledge and experience to solve almost any issue that may arise during the complex clinical trial process.
We recognize that each study is unique and different and there are nuances that need to be resolved proactively.
Our advisory board of top-tier specialists in multiple therapeutic areas engage in the early stages from protocol design in constructive discussions to anticipate challenges and enhance study efficiency throughout the study.